Teladoc (TDOC) Gets $7 Price Target: Can It Double?
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Compare total market funds to determine which has the lowest fees, balancing expense ratios with diversification and performance history.
28,601 articlesBarclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
As gold’s safe-haven appeal faces crowding, retirees are turning to dividend-growing stocks with durable cash flow. T...
As AI accelerates efficiency, middle managers face restructuring across industries. Investors are weighing earnings i...
Pi Network launches two major Pi App Studio updates to boost persistence and AI-driven planning, even as PI token hit...
Bitcoin price just lost momentum after a hotter-than-expected US PPI. Traders weigh how sticky inflation could delay ...
An 11-year retirement window lets savers move traditional IRA funds to a Roth with historically low tax brackets, yet...
Nexxn (NEXN) 2026 earnings signal how the company is navigating growth, profitability, and capital allocation. This g...
Strategy insists it isn’t retreating from its bitcoin holdings as it navigates debt risk thresholds tied to bitcoin’s...
When a blue‑chip like Cisco posts a solid beat and raises guidance, the stock often jumps. This article breaks down t...
Aveanna's Q1 2026 results shed light on how the company is navigating labor costs, payer mix, and geographic expansio...
Bitcoin failed to sustain above $80,000, renewing selling pressure and eyeing lower support. Here’s how the setup cou...
Eli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...